The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.00
Bid: 60.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.333%)
Open: 61.00
High: 61.00
Low: 61.00
Prev. Close: 61.00
PCIP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Patent Case Update

10 Nov 2021 07:00

RNS Number : 8561R
PCI-PAL PLC
10 November 2021
 

 

PCI-PAL PLC

("PCI Pal", "the Company" or "the Group")

Patent Case Update

 

PCI-PAL PLC (AIM: PCIP), the global cloud provider of secure payment solutions for business communications, provides an update on the on-going lawsuit filed by its competitor in the UK and US in September 2021.

 

As notified on 16 September 2021, one of PCI Pal's competitors, the US private equity owned, UK company, Semafone Limited, commenced litigation proceedings against the Company in the UK and the US for alleged patent infringement, which relates to one aspect of how one of the Company's products functions. As previously stated, PCI Pal strongly refutes these claims.

 

PCI Pal has this week filed its UK defence and counterclaim to the UK Court in response to the claims, and has summarised two headline points from this filing below:

 

1. PCI Pal does not infringe the patents as claimed by Semafone;

2. The patent is invalid. It lacks novelty and inventive step over the prior art1;

 

PCI Pal believes that the filing shows a strong defence and, in addition to non-infringement, has provided the Court with information on prior art and invalidity arguments. The Court will assess these points and Semafone's arguments and opine accordingly.

 

In the US, PCI Pal has also started the defence of the claims being made.

 

In the last week, PCI Pal has made an application to the US Court for it to invalidate the Semafone US patents under section 101 of the US Patent Act. The Company believes those patents are overly abstract and thus do not qualify for patentable subject matter under the US patent laws. PCI Pal has made this application to ensure it does not spend significant time and resources on further defence points, based around non-infringement and prior art based invalidity, before having the eligibility of the patents reviewed by the US Court. PCI Pal expects to understand the Court's position on this motion in the next few months.

 

PCI Pal is well funded, with no debt, and given the continued strong trading announced today is in a good position to deal with these allegations. The Group will be reporting costs associated with its defence of these allegations as exceptional items in its accounts.

 

PCI Pal is working with its well-established team of advisors to work towards an outcome that it believes will best benefit the Company, whilst at the same time focusing on delivering its strategic growth plans based on the established momentum within the Group.

 

Given the nature of the claims being made against PCI Pal, it is limited in the information it can provide on the case, but the Board will endeavour to keep investors updated as appropriate.

 

 

1Section 2(1) of the Patents Act 1977 Act states that an invention shall be taken to be new if it does not form part of the state of the art. Section 2(2) then goes on to define the state of the art as to be taken to comprise all matter (whether a product, a process, information about either, or anything else) which has at any time before the priority date of the invention been made available to the public (whether in the UK or elsewhere) by written or oral description, by use or in any other way. This is generally known as "prior art".

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

William Good - Chief Financial Officer

 

 

finnCap (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Marc Milmo/Simon Hicks (Corporate Finance)

Richard Chambers (Corporate Broking)

 

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Nick Rome

+44 (0) 797 122 1972

 

PCIPAL@walbrookpr.com

 

About PCI Pal:

 

PCI Pal is a leading provider of Software-as-a-Service ("SaaS") solutions that empower companies to take payments from their customers securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss. Our products secure payments and data in any business communications environment including voice, chat, social, email, and contact centre. We are integrated to, and resold by, some of the worlds' leading business communications vendors, as well as major payment service providers.

 

The entirety of our product-base is available from our global cloud platform hosted in Amazon Web Services ("AWS"), with regional instances across EMEA, North America, and ANZ.

 

For more information visit www.pcipal.com or follow the team on Linkedin: https://www.linkedin.com/company/pci-pal/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXFNEFDFFFA
Date   Source Headline
17th Apr 20245:45 pmRNSHolding(s) in Company
8th Apr 202410:28 amRNSIssue of Equity & TVR
5th Apr 20247:00 amRNSIssue of Options & Director Share Purchases
4th Apr 202410:24 amRNSIssue of Equity & TVR
28th Mar 20246:15 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSExercise of Options, Director/PCA Dealings & TVR
26th Mar 202410:57 amRNSPDMR Issue of Options
12th Mar 202412:55 pmRNSResult of Oversubscribed Placing & TVR
12th Mar 20247:00 amRNSProposed Placing to raise up to £3.5m
27th Feb 20247:00 amRNSInterim Results, Board Change & Presentations
20th Feb 20247:00 amRNSNotice of Results, Analyst & Investor Presentation
6th Feb 20247:00 amRNSTrading Update & Notice of Results
26th Jan 202412:50 pmRNSUK Patent Case Update
22nd Jan 20244:59 pmRNSHolding(s) in Company
15th Jan 202412:20 pmRNSIssue of Equity
20th Dec 20237:00 amRNSSuccessful Completion of Form of Order Hearing
19th Dec 20237:00 amRNSUK Court Hearing
12th Dec 20231:40 pmRNSResult of AGM
12th Dec 20237:00 amRNSAGM Statement
24th Nov 202310:45 amRNSAnnual Financial Report & Notice of AGM
13th Nov 20237:00 amRNSNew strategic reseller partnership with Zoom
9th Nov 20237:00 amRNSFinal Results, Analyst Briefing & Investor Pres
6th Nov 20237:00 amRNSNotice of Results Analyst Briefing & Investor Pres
5th Oct 202311:49 amRNSIssue of Equity
4th Oct 20235:13 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSDetail on Patent Case Outcome & Trading Update
25th Sep 20235:29 pmRNSTotal Victory for PCI Pal in UK High Court
4th Sep 20237:00 amRNSHolding(s) in Company
26th Jun 202311:33 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSBreach of confidentiality agreement by Sycurio Ltd
30th May 20237:00 amRNSDirector/PDMR Share Purchase
25th May 202311:08 amRNSDirector/PDMR Share Purchase
24th May 20237:00 amRNSTrading and Patent Case Updates
14th Mar 20237:00 amRNSInterim Results, Analyst Briefing & Investor Pres
13th Mar 20237:49 amRNSSVB Update
28th Feb 20237:00 amRNSNotice of Results, Analyst Call & Investor Pres
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
27th Oct 202212:32 pmRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement
20th Oct 20227:00 amRNSPDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Issue of Options
6th Oct 20223:13 pmRNSDirector/PDMR share purchase
4th Oct 202210:37 amRNSAnnual Financial Report & Notice of AGM
22nd Sep 20227:00 amRNSPCI Pal launches open banking payments product
6th Sep 20227:00 amRNSFinal Results, Analyst Briefing & Investor Pres
16th Aug 20227:00 amRNSNotice of Results Analyst Briefing & Investor Pres
27th Jul 20227:00 amRNSTrading Update & Notice of Results
1st Jul 20227:00 amRNSDirectorate Change
30th Jun 20221:56 pmRNSIssue of Equity
28th Jun 20227:00 amRNSUpdate on Patent Infringement Claims

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.